# Treace Medical Concepts, Inc.: filings

TMCI · Nasdaq · CIK 1630627 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tmci.md) · [Financials](/companies/tmci/financials.md) · [Filings](/companies/tmci/filings.md) · [Insiders](/companies/tmci/insiders.md)

## Reports and events: 77 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 264, 8-K 47, 3 22, 10-Q 17, SC 13G/A 10, SCHEDULE 13G/A 10, 144 7, S-8 6, SC 13G 6, 10-K 5, DEF 14A 5, DEFA14A 5, 5 4, ARS 4, CORRESP 4, D 3, D/A 3, 424B5 2, SCHEDULE 13G 2, UPLOAD 2, 10-Q/A 1, 424B4 1, 4/A 1, 8-A12B 1, CERT 1, DRS 1, EFFECT 1, S-1 1, S-1/A 1, S-1MEF 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-07 | 07:12 ET | [10-Q](/filings/0001630627-26-000018.md) | Quarterly report, period 2026-06-30 | 0001630627-26-000018 |
| 2026-08-07 | 07:10 ET | [8-K](/filings/0001630627-26-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001630627-26-000017 |
| 2026-05-20 | 17:30 ET | [8-K](/filings/0001630627-26-000014.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001630627-26-000014 |
| 2026-05-08 | 07:10 ET | [10-Q](/filings/0001193125-26-213322.md) | Quarterly report, period 2026-03-31 | 0001193125-26-213322 |
| 2026-05-08 | 07:05 ET | [8-K](/filings/0001193125-26-213267.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-213267 |
| 2026-04-09 | 07:00 ET | [8-K](/filings/0001630627-26-000010.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001630627-26-000010 |
| 2026-04-06 | 08:48 ET | [DEF 14A](/filings/0001630627-26-000005.md) | Proxy statement, period 2026-04-03 | 0001630627-26-000005 |
| 2026-02-27 | 07:14 ET | [10-K](/filings/0001193125-26-079167.md) | Annual report, period 2025-12-31 | 0001193125-26-079167 |
| 2026-02-27 | 07:10 ET | [8-K](/filings/0001193125-26-079163.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-079163 |
| 2026-01-13 | 08:54 ET | [8-K](/filings/0001193125-26-011177.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-011177 |
| 2025-12-18 | 08:44 ET | [8-K](/filings/0001193125-25-323802.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-323802 |
| 2025-11-06 | 16:14 ET | [10-Q](/filings/0001193125-25-269556.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269556 |
| 2025-11-06 | 16:07 ET | [8-K](/filings/0001193125-25-269481.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-269481 |
| 2025-08-07 | 16:17 ET | [10-Q](/filings/0000950170-25-105059.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105059 |
| 2025-08-07 | 16:13 ET | [8-K](/filings/0000950170-25-105039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105039 |
| 2025-05-21 | 16:30 ET | [8-K](/filings/0000950170-25-075805.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-075805 |
| 2025-05-08 | 16:10 ET | [10-Q](/filings/0000950170-25-066953.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066953 |
| 2025-05-08 | 16:05 ET | [8-K](/filings/0000950170-25-066915.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066915 |
| 2025-04-07 | 08:10 ET | [DEF 14A](/filings/0000950170-25-051369.md) | Proxy statement, period 2025-04-07 | 0000950170-25-051369 |
| 2025-04-07 | 08:05 ET | [8-K](/filings/0000950170-25-051362.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-051362 |
| 2025-02-27 | 16:06 ET | [10-K](/filings/0000950170-25-029029.md) | Annual report, period 2024-12-31 | 0000950170-25-029029 |
| 2025-02-27 | 16:04 ET | [8-K](/filings/0000950170-25-029009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-029009 |
| 2025-01-13 | 08:05 ET | [8-K](/filings/0000950170-25-004578.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-004578 |
| 2024-11-05 | 16:08 ET | [10-Q](/filings/0000950170-24-121460.md) | Quarterly report, period 2024-09-30 | 0000950170-24-121460 |
| 2024-11-05 | 16:06 ET | [8-K](/filings/0000950170-24-121456.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-121456 |
| 2024-10-15 | 16:25 ET | [8-K](/filings/0000950170-24-114699.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-114699 |
| 2024-08-06 | 16:08 ET | [10-Q](/filings/0000950170-24-091787.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091787 |
| 2024-08-06 | 16:05 ET | [8-K](/filings/0000950170-24-091777.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091777 |
| 2024-05-22 | 17:00 ET | [8-K](/filings/0000950170-24-063565.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-063565 |
| 2024-05-07 | 16:10 ET | [10-Q](/filings/0000950170-24-054480.md) | Quarterly report, period 2024-03-31 | 0000950170-24-054480 |
| 2024-05-07 | 16:08 ET | [8-K](/filings/0000950170-24-054475.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-054475 |
| 2024-04-02 | 16:30 ET | [DEF 14A](/filings/0000950170-24-040228.md) | Proxy statement, period 2024-04-02 | 0000950170-24-040228 |
| 2024-02-27 | 16:29 ET | [10-K](/filings/0000950170-24-021228.md) | Annual report, period 2023-12-31 | 0000950170-24-021228 |
| 2024-02-27 | 16:13 ET | [8-K](/filings/0000950170-24-021152.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-021152 |
| 2024-01-10 | 18:19 ET | [8-K](/filings/0000950170-24-003448.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-003448 |
| 2024-01-08 | 08:16 ET | [8-K](/filings/0000950170-24-002719.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-002719 |
| 2023-11-09 | 16:14 ET | [10-Q](/filings/0000950170-23-062068.md) | Quarterly report, period 2023-09-30 | 0000950170-23-062068 |
| 2023-11-09 | 16:07 ET | [8-K](/filings/0000950170-23-062026.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062026 |
| 2023-08-09 | 08:09 ET | [10-Q](/filings/0000950170-23-040159.md) | Quarterly report, period 2023-06-30 | 0000950170-23-040159 |
| 2023-08-08 | 16:08 ET | [8-K](/filings/0000950170-23-039795.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-039795 |
| 2023-06-13 | 17:09 ET | [8-K](/filings/0000950170-23-027758.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0000950170-23-027758 |
| 2023-06-01 | 16:18 ET | [8-K](/filings/0000950170-23-025707.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-025707 |
| 2023-05-26 | 17:19 ET | [8-K](/filings/0000950170-23-024559.md) | 5.07 Shareholder vote results | 0000950170-23-024559 |
| 2023-05-09 | 08:01 ET | [10-Q](/filings/0000950170-23-019154.md) | Quarterly report, period 2023-03-31 | 0000950170-23-019154 |
| 2023-05-08 | 16:14 ET | [8-K](/filings/0000950170-23-018823.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-018823 |
| 2023-04-04 | 07:20 ET | [DEF 14A](/filings/0000950170-23-011691.md) | Proxy statement, period 2023-05-23 | 0000950170-23-011691 |
| 2023-03-10 | 16:13 ET | [8-K](/filings/0000950170-23-007283.md) | 8.01 Other events | 0000950170-23-007283 |
| 2023-03-08 | 09:09 ET | [10-K](/filings/0000950170-23-006603.md) | Annual report, period 2022-12-31 | 0000950170-23-006603 |
| 2023-03-07 | 16:07 ET | [8-K](/filings/0000950170-23-006457.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-006457 |
| 2023-02-23 | 16:34 ET | [8-K](/filings/0000950170-23-004148.md) | 5.02 Departure or appointment of officers or directors | 0000950170-23-004148 |

Page 1 of 2. [Older](/companies/tmci/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 04:31 ET. No prices; not investment advice.